American Trust Dexcom Inc Transaction History

American Trust

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Jun 11, 2024	BUY	$114.22 - $140.1 $174,528 - $214,072	1,528 New	1,528 $211,000
Q2 2023 Aug 14, 2023	SELL	$112.47 - $130.98 $4,948 - $5,763	-44 Reduced 2.31%	1,859 $238,000
Q1 2023 May 22, 2023	SELL	$104.0 - $122.92 $10,712 - $12,660	-103 Reduced 5.13%	1,903 $221,000
Q4 2022 Feb 16, 2023	BUY	$84.98 - $122.67 $170,469 - $246,076	2,006 New	2,006 $227,000
Q2 2022 Oct 03, 2022	SELL	$67.99 - $132.89 $33,315 - $65,116	-490 Closed	0 $0
Q1 2022 Jun 08, 2022	SELL	$94.08 - $130.2 $8,090 - $11,197	-86 Reduced 14.93%	490 $251,000
Q4 2021 Mar 17, 2022	BUY	$129.87 - $162.82 $74,805 - $93,784	576 New	576 $309,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of American Trust, based on Form 13F filings with the SEC.

Stay updated on American Trust with notifications on news.